Index of reports
> Cases with Interstitial Lung Disease (35)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neoral (Cyclosporine) where reactions include interstitial lung disease. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 35 Next >>
Possible Neoral side effects in 3 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-08
Patient: 3 year old female
Reactions: Cytomegalovirus Hepatitis, Hepatic Function Abnormal, Bronchiectasis, Interstitial Lung Disease, Anaemia Haemolytic Autoimmune, Combined Immunodeficiency
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Dexamethasone; Prednisolone; Ganciclovir
Possible Neoral side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-30
Patient: 64 year old male
Reactions: Interstitial Lung Disease, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Cyclophosphamide
Possible Neoral side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-27
Patient: 64 year old male
Reactions: Interstitial Lung Disease, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Cyclophosphamide
Possible Neoral side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-27
Patient: 64 year old male
Reactions: Interstitial Lung Disease, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Cyclophosphamide
Possible Neoral side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18
Patient: male
Reactions: Gastrointestinal Haemorrhage, Disseminated Intravascular Coagulation, Enterococcal Infection, Coagulopathy, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Pneumocystis Jiroveci Pneumonia, Anal Fistula, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Gastrointestinal Ulcer Haemorrhage, Restlessness, Hyperglycaemia, Anaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Large Intestinal Ulcer, Ileal Fistula, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Anal Haemorrhage, Purulence, Hypertension
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Bredinin
Dosage: 100 mg, daily
Administration route: Oral
End date: 2011-03-08
Neoral
Dosage: 100 mg, daily
Administration route: Oral
Start date: 2010-11-18
End date: 2011-03-15
Rituximab
Dosage: unk ukn, unk
Prograf
Dosage: 2 mg, daily
Administration route: Oral
End date: 2011-11-17
Prednisolone
Dosage: 10 mg, unk
End date: 2011-03-22
Prednisolone
Dosage: 10 mg, daily
Administration route: Oral
End date: 2011-03-18
Neoral
Dosage: 50 mg, daily
Administration route: Oral
Indication: Renal Transplant
End date: 2011-03-15
Mycophenolate Mofetil
Indication: Renal Transplant
Other drugs received by patient: Insulin
Possible Neoral side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18
Patient: male
Reactions: Gastrointestinal Haemorrhage, Coagulopathy, Disseminated Intravascular Coagulation, Enterococcal Infection, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Anal Fistula, Pneumocystis Jiroveci Pneumonia, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Restlessness, Gastrointestinal Ulcer Haemorrhage, Anaemia, Hyperglycaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Ileal Fistula, Large Intestinal Ulcer, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Purulence, Anal Haemorrhage, Hypertension
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Rituximab
Dosage: unk ukn, unk
Prednisolone
Dosage: 10 mg, daily
Administration route: Oral
End date: 2011-03-18
Neoral
Dosage: 50 mg, daily
Administration route: Oral
Indication: Renal Transplant
End date: 2011-03-15
Bredinin
Dosage: 100 mg, daily
Administration route: Oral
End date: 2011-03-08
Mycophenolate Mofetil
Indication: Renal Transplant
Prograf
Dosage: 2 mg, daily
Administration route: Oral
End date: 2011-11-17
Neoral
Dosage: 100 mg, daily
Administration route: Oral
Start date: 2010-11-18
End date: 2011-03-15
Prednisolone
Dosage: 10 mg, unk
End date: 2011-03-22
Other drugs received by patient: Insulin
Possible Neoral side effects in male
Reported by a physician from China on 2012-07-16
Patient: male, weighing 50.0 kg (110.0 pounds)
Reactions: Weight Decreased, Fatigue, Interstitial Lung Disease, Diabetes Mellitus, DRY Mouth, Lung Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neoral
Indication: Prophylaxis Against Transplant Rejection
Mycophenolic Acid
Dosage: 1500 mg, daily
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2012-01-04
Neoral
Dosage: 200 mg, daily
Administration route: Oral
Indication: Renal Transplant
Start date: 2012-01-04
End date: 2012-06-11
Possible Neoral side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-18
Patient: 65 year old male
Reactions: Portal Hypertension, Hepatic Function Abnormal, Polyarteritis Nodosa, Hepatic Failure, Ascites, Pulmonary Fibrosis, Renal Impairment, Interstitial Lung Disease, Nodular Regenerative Hyperplasia, Chronic Hepatitis, Necrosis of Artery, Hepatic Cirrhosis, Arterial Stenosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Prednisolone; Prednisolone; Oxygen
Possible Neoral side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-18
Patient: 65 year old male
Reactions: Portal Hypertension, Hepatic Function Abnormal, Polyarteritis Nodosa, Hepatic Failure, Pulmonary Fibrosis, Ascites, Renal Impairment, Interstitial Lung Disease, Nodular Regenerative Hyperplasia, Chronic Hepatitis, Necrosis of Artery, Hepatic Cirrhosis, Arterial Stenosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Prednisolone; Prednisolone; Oxygen
Possible Neoral side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-18
Patient: 65 year old male
Reactions: Portal Hypertension, Polyarteritis Nodosa, Hepatic Function Abnormal, Hepatic Failure, Pulmonary Fibrosis, Ascites, Renal Impairment, Interstitial Lung Disease, Nodular Regenerative Hyperplasia, Chronic Hepatitis, Hepatic Cirrhosis, Arterial Stenosis, Necrosis of Artery
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Prednisolone; Prednisolone; Oxygen
Possible Neoral side effects in male
Reported by a physician from Japan on 2012-06-14
Patient: male, weighing 63.0 kg (138.6 pounds)
Reactions: Drug Ineffective, Conjunctivitis, Malnutrition, Hypoglycaemia, Hyperuricaemia, Dysgeusia, Multi-Organ Failure, Renal Failure, Interstitial Lung Disease, Oedema Peripheral, Bronchitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Stelara
Indication: Psoriasis
Start date: 2011-08-10
End date: 2011-09-07
Oxarol
Administration route: Topical
Indication: Psoriasis
Start date: 2011-10-04
End date: 2011-11-02
Neoral
Administration route: Oral
Indication: Psoriasis
Start date: 2011-10-04
End date: 2011-10-21
Neoral
Administration route: Oral
End date: 2011-09-05
Other drugs received by patient: Cholebrine; Insulin; Metformin HCL; Polaprezinc; Ensure; Lasix; Urinorm; Ferrous Citrate; Juvelan; Amaryl; Nerisona; Levofloxacin; Rheumatrex; Allegra; Dovonex; Insulin Glargine; Loxonin; Vitamedin; Levofloxacin; Lansoprazole; Rebamipide
Possible Neoral side effects in female
Reported by a physician from Japan on 2012-06-07
Patient: female, weighing 13.0 kg (28.6 pounds)
Reactions: Nasopharyngitis, Nausea, Pyrexia, Respiratory Syncytial Virus Infection, Renal Impairment, Diarrhoea, Interstitial Lung Disease, Heart Transplant Rejection, Rash Erythematous, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prograf
Dosage: 4.5 mg, unk
Administration route: Oral
Start date: 2006-01-23
End date: 2006-02-16
Certican
Dosage: 1 mg, unk
Administration route: Oral
Start date: 2006-01-30
End date: 2006-02-03
Certican
Dosage: 0.75 mg, unk
Administration route: Oral
Start date: 2006-02-03
End date: 2006-04-24
Certican
Dosage: 0.5 mg, unk
Administration route: Oral
Indication: Heart Transplant
Start date: 2006-01-23
End date: 2006-01-30
Neoral
Indication: Heart Transplant
Cellcept
Administration route: Oral
Indication: Heart Transplant
Start date: 2009-02-01
Certican
Dosage: 1 mg, daily
Administration route: Oral
Start date: 2008-01-23
End date: 2009-01-22
Azathioprine
Administration route: Oral
Indication: Heart Transplant
Tacrolimus
Indication: Heart Transplant
Prograf
Dosage: 4.8 mg, unk
Administration route: Oral
Indication: Heart Transplant
End date: 2006-01-23
Prograf
Dosage: 4.0 mg, unk
Administration route: Oral
Start date: 2006-03-20
End date: 2006-04-24
Certican
Dosage: unk
Administration route: Oral
End date: 2009-02-05
Certican
Dosage: unk
Prograf
Dosage: 3.0 mg, unk
Administration route: Oral
Start date: 2006-02-16
End date: 2006-03-20
Other drugs received by patient: Everolimus; Tenormin; Sirolimus; Famotidine
Possible Neoral side effects in 63 year old male
Reported by a physician from Japan on 2012-05-23
Patient: 63 year old male
Reactions: Dysgeusia, Drug Level Increased, Interstitial Lung Disease, Drug Interaction, Pyrexia, Cough
Drug(s) suspected as cause:
Neoral
Other drugs received by patient possibly interacting with the suspect drug: Afinitor
Dosage: 5 mg, daily
Administration route: Oral
Start date: 2012-04-14
End date: 2012-04-16
Afinitor
Dosage: 10 mg, daily
Administration route: Oral
Indication: Renal Cell Carcinoma
Start date: 2012-03-27
End date: 2012-04-13
Possible Neoral side effects in 68 year old male
Reported by a pharmacist from Japan on 2012-05-22
Patient: 68 year old male
Reactions: Interstitial Lung Disease
Drug(s) suspected as cause:
Neoral
Possible Neoral side effects in 63 year old male
Reported by a physician from Japan on 2012-05-15
Patient: 63 year old male
Reactions: Interstitial Lung Disease, Drug Level Increased, Drug Interaction, Pyrexia, Cough
Drug(s) suspected as cause:
Neoral
Other drugs received by patient possibly interacting with the suspect drug: Afinitor
Dosage: 5 mg, unk
Administration route: Oral
Start date: 2012-04-14
End date: 2012-04-16
Afinitor
Dosage: 10 mg, unk
Administration route: Oral
Indication: Renal Cell Carcinoma
Start date: 2012-03-27
End date: 2012-04-13
Possible Neoral side effects in male
Reported by a physician from Japan on 2012-05-04
Patient: male, weighing 63.0 kg (138.6 pounds)
Reactions: Diabetes Mellitus, Drug Ineffective, Malnutrition, Conjunctivitis, Hyperuricaemia, Blood Glucose Decreased, Multi-Organ Failure, Dysgeusia, Renal Failure, Interstitial Lung Disease, Oedema Peripheral, Bronchitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Stelara
Indication: Psoriasis
Start date: 2011-08-10
End date: 2011-09-07
Neoral
Administration route: Oral
Indication: Psoriasis
Start date: 2011-10-04
End date: 2011-10-21
Oxarol
Administration route: Topical
Indication: Psoriasis
Start date: 2011-10-04
End date: 2011-11-02
Neoral
Administration route: Oral
End date: 2011-09-05
Other drugs received by patient: Levofloxacin; Ensure; Insulin; Dovonex; Insulin Glargine; Allegra; Nerisona; Ferrous Citrate; Juvelan; Urinorm; Cholebrine; Amaryl; Rheumatrex; Polaprezinc; Rebamipide; Loxonin; Lasix; Vitamedin; Lansoprazole; Metformin HCL; Levofloxacin
Possible Neoral side effects in 63 year old male
Reported by a physician from Japan on 2012-05-02
Patient: 63 year old male
Reactions: Drug Level Increased, Interstitial Lung Disease, Drug Interaction, Pyrexia, Cough
Drug(s) suspected as cause:
Neoral
Other drugs received by patient possibly interacting with the suspect drug: Afinitor
Dosage: 5 mg, unk
Administration route: Oral
Start date: 2012-04-14
End date: 2012-04-16
Afinitor
Dosage: 10 mg, unk
Administration route: Oral
Indication: Renal Cell Carcinoma
Start date: 2012-03-27
End date: 2012-04-13
Possible Neoral side effects in 68 year old male
Reported by a pharmacist from Japan on 2012-05-02
Patient: 68 year old male
Reactions: Interstitial Lung Disease
Drug(s) suspected as cause:
Neoral
Possible Neoral side effects in 63 year old male
Reported by a physician from Japan on 2012-04-27
Patient: 63 year old male
Reactions: Interstitial Lung Disease, Drug Level Increased, Drug Interaction, Pyrexia, Cough
Drug(s) suspected as cause:
Neoral
Other drugs received by patient possibly interacting with the suspect drug: Afinitor
Dosage: 5 mg, unk
Administration route: Oral
Start date: 2012-04-14
End date: 2012-04-16
Afinitor
Dosage: 10 mg, unk
Administration route: Oral
Indication: Renal Cell Carcinoma
Start date: 2012-03-27
End date: 2012-04-13
Possible Neoral side effects in 25 year old male
Reported by a consumer/non-health professional from Japan on 2012-04-23
Patient: 25 year old male, weighing 57.0 kg (125.4 pounds)
Reactions: Eyelid Oedema, Pneumonia Viral, Gastrointestinal Haemorrhage, Hepatic Function Abnormal, Graft Versus Host Disease, Disseminated Intravascular Coagulation, Headache, Pyrexia, Oral Herpes, Pneumonia Cytomegaloviral, Generalised Oedema, Pericardial Effusion, Pneumocystis Jiroveci Pneumonia, Interstitial Lung Disease, Liver Function Test Abnormal, Pleural Effusion, Enterocolitis, Bronchopulmonary Aspergillosis, White Blood Cell Count Decreased, Anaemia, Pulmonary Haemorrhage, Renal Impairment, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Itraconazole
Dosage: capsule;400-200mg/day(06jul-16jul09)inj.
Administration route: Oral
Indication: Prophylaxis
Start date: 2009-06-06
End date: 2009-07-16
Foscavir
Dosage: form:inj1 df= 10 unit nos
Start date: 2009-07-10
End date: 2009-07-16
Bactrim
Dosage: 1df=1tab;800mg/day(02jul-18jul09)inj.
Administration route: Oral
Indication: Antibiotic Prophylaxis
Start date: 2009-04-14
End date: 2009-07-16
Farom
Administration route: Oral
Start date: 2009-04-28
End date: 2009-05-01
Neoral
Dosage: 09jul-16jul09. 125mg/day sandimmun:inj:50mg/dy:09jul-16jul09
Administration route: Oral
Indication: Prophylaxis
Start date: 2009-04-14
End date: 2009-07-08
Sprycel
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-04-16
End date: 2009-07-08
Maxipime
Start date: 2009-04-24
End date: 2009-04-27
Other drugs received by patient: Ceftazidime; Solu-Medrol; Ambisome; Piperacillin and Tazobactam; Pentamidine Isethionate; Ganciclovir; Meropenem; Omegacin; Sandimmune; Prednisolone
Possible Neoral side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-20
Patient: male
Reactions: Gastrointestinal Haemorrhage, Enterococcal Infection, Coagulopathy, Disseminated Intravascular Coagulation, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Anal Fistula, Pneumocystis Jiroveci Pneumonia, Colonic Fistula, Circulatory Collapse, Acute Respiratory Distress Syndrome, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Restlessness, Gastrointestinal Ulcer Haemorrhage, Hyperglycaemia, Anaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Shock Haemorrhagic, Oral Administration Complication, Ileal Ulcer, Large Intestinal Ulcer, Ileal Fistula, Interstitial Lung Disease, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Respiratory Failure, Diarrhoea, Sepsis, Purulence, Anal Haemorrhage, Hypertension
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Bredinin
Dosage: 100 mg, daily
Administration route: Oral
End date: 2011-03-08
Prednisolone
Dosage: 10 mg, unk
End date: 2011-03-22
Prograf
Dosage: 2 mg, daily
Administration route: Oral
Start date: 2006-11-01
End date: 2011-11-17
Rituximab
Dosage: unk ukn, unk
Neoral
Dosage: 100 mg, daily
Administration route: Oral
Start date: 2010-11-18
End date: 2011-03-15
Prednisolone
Dosage: 10 mg, daily
Administration route: Oral
Start date: 2006-11-01
End date: 2011-03-18
Neoral
Dosage: 50 mg, daily
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-11-18
End date: 2011-03-15
Other drugs received by patient: Insulin
Possible Neoral side effects in 72 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-10
Patient: 72 year old female
Reactions: Dyspnoea, Interstitial Lung Disease, Rash, Pyrexia, Cough
Drug(s) suspected as cause:
Infliximab
Dosage: unk ukn, unk
Start date: 2010-08-01
Neoral
Dosage: unk ukn, unk
Administration route: Oral
Indication: Psoriasis
End date: 2010-08-01
Adalimumab
Dosage: unk ukn, unk
Indication: Psoriasis
Other drugs received by patient: Humira
Possible Neoral side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-10
Patient: 55 year old male
Reactions: Interstitial Lung Disease, Arthralgia, Cell Marker Increased
Drug(s) suspected as cause:
Remicade
Dosage: unk ukn, unk
Indication: Psoriatic Arthropathy
Start date: 2008-08-01
End date: 2010-03-01
Neoral
Indication: Psoriasis
Neoral
Dosage: unk ukn, unk
Indication: Psoriatic Arthropathy
Start date: 1990-01-01
End date: 2008-08-01
Possible Neoral side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-10
Patient: 55 year old male
Reactions: Arthralgia, Interstitial Lung Disease, Cell Marker Increased
Drug(s) suspected as cause:
Remicade
Dosage: unk ukn, unk
Indication: Psoriatic Arthropathy
Start date: 2008-08-01
End date: 2010-03-01
Neoral
Dosage: unk ukn, unk
Indication: Psoriatic Arthropathy
Start date: 1990-01-01
End date: 2008-08-01
Neoral
Indication: Psoriasis
Possible Neoral side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-10
Patient: 50 year old male
Reactions: Renal Impairment, Interstitial Lung Disease, Cell Marker Increased
Drug(s) suspected as cause:
Sandimmune
Dosage: unk ukn, unk
Administration route: Oral
Indication: Erythrodermic Psoriasis
Start date: 1994-01-01
Neoral
Dosage: unk ukn, unk
Administration route: Oral
Indication: Psoriasis
Start date: 1994-01-01
End date: 2008-08-01
Neoral
Indication: Erythrodermic Psoriasis
Remicade
Dosage: unk ukn, unk
Indication: Erythrodermic Psoriasis
Start date: 2008-08-01
End date: 2011-05-01
Possible Neoral side effects in 72 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-10
Patient: 72 year old female
Reactions: Dyspnoea, Interstitial Lung Disease, Rash, Pyrexia, Cough
Drug(s) suspected as cause:
Infliximab
Dosage: unk ukn, unk
Start date: 2010-08-01
Adalimumab
Dosage: unk ukn, unk
Indication: Psoriasis
Neoral
Dosage: unk ukn, unk
Administration route: Oral
Indication: Psoriasis
End date: 2010-08-01
Other drugs received by patient: Humira
Possible Neoral side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-10
Patient: 50 year old male
Reactions: Renal Impairment, Interstitial Lung Disease, Cell Marker Increased
Drug(s) suspected as cause:
Sandimmune
Dosage: unk ukn, unk
Administration route: Oral
Indication: Erythrodermic Psoriasis
Start date: 1994-01-01
Neoral
Indication: Erythrodermic Psoriasis
Remicade
Dosage: unk ukn, unk
Indication: Erythrodermic Psoriasis
Start date: 2008-08-01
End date: 2011-05-01
Neoral
Dosage: unk ukn, unk
Administration route: Oral
Indication: Psoriasis
Start date: 1994-01-01
End date: 2008-08-01
Possible Neoral side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-14
Patient: male
Reactions: Gastrointestinal Haemorrhage, Endocarditis Bacterial, Aortic Stenosis, Tricuspid Valve Incompetence, Death, Colonic Polyp, Dyspnoea Exertional, Interstitial Lung Disease, Cerebral Artery Embolism, Blindness Unilateral, Hypoxia, Acute Myocardial Infarction, Cardiac Failure Congestive, Malnutrition, Renal Failure Chronic, Cerebrovascular Accident, Hyperlipidaemia, Renal Impairment, Embolism, Mitral Valve Incompetence, Leukocytosis, Aortic Valve Incompetence, Hypertension, Mitral Valve Stenosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Neoral
Dosage: 75 mg, unk
Neoral
Dosage: 25 mg, bid
Administration route: Oral
Neoral
Dosage: 125 mg, unk
Administration route: Oral
Other drugs received by patient: Citalopram; Temazepam; Metoprolol; Renagel; Azathioprine; Penicillin; Cipro; Ultram; Prednisone; Albuterol; Sodium Bicarbonate; Buspar; Acetaminophen; Guaifenesin; Ativan; Ambien; Celexa; Vitamin D; Simvastatin; Lovastatin
Possible Neoral side effects in
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-02-22
Patient:
Reactions: Interstitial Lung Disease
Drug(s) suspected as cause:
Certican
Dosage: 0.25 mg, bid
Indication: Heart Transplant
Neoral
Dosage: unk ukn, unk
Indication: Renal Transplant
Possible Neoral side effects in female
Reported by a physician from Belgium on 2011-12-15
Patient: female, weighing 56.2 kg (123.6 pounds)
Reactions: Diabetes Mellitus, Interstitial Lung Disease, Anaemia, Blood Creatinine Increased, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neoral
Dosage: 50 mg, bid
Indication: Renal Transplant
Everolimus
Dosage: 3 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2009-12-05
End date: 2011-09-23
Prednisolone
Dosage: 4 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2009-11-07
Myfortic
Dosage: 720 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2009-12-16
Other drugs received by patient: Glurenorm; Olmesartan Medoxomil; Bumetanide; Insulatard NPH Human; Sulfamethoxazole and Trimethoprim
Page 1 Next >>
|